Investigative Site US233

Washington D.C., District of Columbia 20060

0 studies enrolling now · 1 studies all time

What they study most

Hidradenitis Suppurativa (HS)

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS) — Completed